Lancet Oncology

New drug cuts risk of deadly transplant side effect in half

A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive ...

Dec 02, 2013
popularity 5 / 5 (1) | comments 0

Researchers discover breakthrough in ovarian cancer

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors ...

Feb 14, 2013
popularity 5 / 5 (3) | comments 0 | with audio podcast

New drug shrinks brain tumours in melanoma patients

(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.

Oct 08, 2012
popularity not rated yet | comments 0 | with audio podcast

Study supports tobacco link to ovarian cancer

(Medical Xpress)—Researchers from Curtin University's School of Public Health have contributed to a comprehensive international study examining risk factors for ovarian cancer.

Sep 12, 2012
popularity not rated yet | comments 0 | with audio podcast

Genetic markers hope for new brain tumor treatments

Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.

Jun 15, 2012
popularity 5 / 5 (1) | comments 0 | with audio podcast